rs121908023

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PP3_StrongPP5_Moderate

The NM_024740.2(ALG9):​c.860A>G​(p.Tyr287Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000075 ( 0 hom. )

Consequence

ALG9
NM_024740.2 missense

Scores

14
4
1

Clinical Significance

Likely pathogenic criteria provided, single submitter P:3

Conservation

PhyloP100: 8.02

Publications

9 publications found
Variant links:
Genes affected
ALG9 (HGNC:15672): (ALG9 alpha-1,2-mannosyltransferase) This gene encodes an alpha-1,2-mannosyltransferase enzyme that functions in lipid-linked oligosaccharide assembly. Mutations in this gene result in congenital disorder of glycosylation type Il. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
ALG9 Gene-Disease associations (from GenCC):
  • ALG9-associated autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • ALG9-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Orphanet
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Gillessen-Kaesbach-Nishimura syndrome
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.978
PP5
Variant 11-111853415-T-C is Pathogenic according to our data. Variant chr11-111853415-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3749.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG9NM_024740.2 linkc.860A>G p.Tyr287Cys missense_variant Exon 8 of 15 ENST00000616540.5 NP_079016.2 Q9H6U8-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG9ENST00000616540.5 linkc.860A>G p.Tyr287Cys missense_variant Exon 8 of 15 1 NM_024740.2 ENSP00000482437.1 Q9H6U8-3
ENSG00000258529ENST00000622211.4 linkc.1559A>G p.Tyr520Cys missense_variant Exon 12 of 19 2 ENSP00000482396.1 A0A087WZ62

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152178
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.0000602
AC:
15
AN:
249006
AF XY:
0.0000444
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000580
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000975
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000753
AC:
110
AN:
1461728
Hom.:
0
Cov.:
32
AF XY:
0.0000646
AC XY:
47
AN XY:
727176
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.0000447
AC:
2
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000881
AC:
98
AN:
1111906
Other (OTH)
AF:
0.000149
AC:
9
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152178
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41460
American (AMR)
AF:
0.00
AC:
0
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5208
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68014
Other (OTH)
AF:
0.000480
AC:
1
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000386
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.0000579
AC:
7
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Gillessen-Kaesbach-Nishimura syndrome;C2931006:ALG9 congenital disorder of glycosylation Pathogenic:1
Jan 12, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALG9 congenital disorder of glycosylation Pathogenic:1
Jul 15, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

ALG9-related disorder Pathogenic:1
Sep 06, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The ALG9 c.860A>G variant is predicted to result in the amino acid substitution p.Tyr287Cys. This variant has previously been reported in the homozygous state in multiple unrelated individuals who presented with autosomal recessive congenital disorder of glycosylation, type Il (Weinstein et al. 2005. PubMed ID: 15945070, reported as p.Y286C; Davis et al. 2017. PubMed ID: 28932688; Vleugels et al. 2009. PubMed ID: 19451548, reported as p.Y286C). We classify this variant as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.91
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.36
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.72
D;.;.;.;.
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.94
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D;D;D;D
M_CAP
Uncertain
0.13
D
MetaRNN
Pathogenic
0.98
D;D;D;D;D
MetaSVM
Uncertain
0.57
D
MutationAssessor
Pathogenic
3.5
H;.;.;H;.
PhyloP100
8.0
PrimateAI
Pathogenic
0.81
D
PROVEAN
Pathogenic
-8.6
.;D;D;.;.
REVEL
Pathogenic
0.87
Sift
Pathogenic
0.0
.;D;D;.;.
Sift4G
Pathogenic
0.0
D;D;D;D;D
Polyphen
1.0
D;.;.;D;.
Vest4
0.92
MutPred
0.95
Gain of sheet (P = 0.0827);.;.;Gain of sheet (P = 0.0827);.;
MVP
0.98
MPC
1.2
ClinPred
0.99
D
GERP RS
6.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.47
gMVP
0.98
Mutation Taster
=3/97
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908023; hg19: chr11-111724138; API